SPDR S&P Pharmaceuticals ETF
XPH
XPH
72 hedge funds and large institutions have $105M invested in SPDR S&P Pharmaceuticals ETF in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 73 → 72 (-1)
10% less capital invested
Capital invested by funds: $117M → $105M (-$12M)
Holders
72
Holding in Top 10
–
Calls
$2.2M
Puts
$2K
Top Buyers
| 1 | +$2.23M | |
| 2 | +$868K | |
| 3 | +$838K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$636K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$565K |
Top Sellers
| 1 | -$4.22M | |
| 2 | -$3.54M | |
| 3 | -$3.19M | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$2.97M |
| 5 |
BCM
Brookstone Capital Management
Wheaton,
Illinois
|
-$2.16M |